Humanscape

Humanscape

Trading
14,289 Views
Humanscape can provide practical help for patients to overcome their diseases through intellectual and emotional interaction with each other based on community activities. This process is expected to generate and collect a high volume of patient data, namely PGHD, on various disease groups.<br /> <br /> Furthermore, Humanscape facilitates active research into incurable diseases and the development of new drugs by linking patients to external industry sectors such as pharmaceutical firms and research institutes and helps patients to avoid complications and enjoy healthy lives through the continuous self-management of their lifestyle and symptoms. <br /> <br /> With these services, Humanscape is taking steps to liberate patients from incurable diseases, as its contribution to a world where everyone is healthy.
General
Website: Visit
White paper: Read
Bounty: Bounty
Pre-sale Time: 22 June 2018 - 29 June 2018
Whitelist/KYC: Whitelist + KYC
Country: Hong Kong
Token info
Ticker: HUM
Platform: Ethereum
Token Type: ERC20
Total supply: 1,084,734,273.00 HUM
Financial
ICO Price: ≈ 0.01 USD
Screenshots taken on 25 Jun 2018
Q1 2016
Company Incorporation - Seoul, Korea (team foundation : 2014)
Q2 2016
Development and Launch of ‘Beautycare’, a mobile application for aftercare services
Q3 2016
Angel Investment Promotion from ‘Mashup Angels’ (Taek-Kyung Lee, CEO and Founder of ‘Daum’)
Q4 2016
Client Usage Agreement with ‘Dream Medical Group’ and ‘DA Plastic Surgery’
Q1 2017
Development and Beta test of ‘Helen’, Mobile Medical Assistant<br />
Q2 2017
Official Launch of ‘Helen’<br />
Q3 2017
Follow-up Investment Promotion from ‘Magellan Technology Investment(VC)’<br />
Q4 2017
Acquisition of 10,000 PHR Data from ‘Beautycare’ and ‘Helen’<br /> <br /> Concept Building of ‘Humanscape’, a Health Information Ecosystem
Q1 2018
Whitepaper publication<br /> <br /> Company Incorporation - Hongkong
Q2 2018
‘Humanscape’ MVP Development Begins<br /> <br /> Pre-sale 1st, 2nd and 3rd round
Q3 2018
Main sale<br /> <br /> Test group(patients/health professionals) building<br /> <br /> Indonesia incorporation / Organization PoC
Q4 2018
Exchange listing<br /> <br /> MVP release<br /> <br /> Alpha test<br /> <br /> PoC with global pharmaceutical companies and Contract research institutes
Q1 2019
Beta test closing<br /> <br /> Soft launch (South Korea, Indonesia)<br /> <br /> Business model validation
Q2 2019
Main launch (South Korea, Indonesia)<br />
Min-hoo Chang
CEO
Participates in a number of projects
Won-woo Je
CSO
Participates in a number of projects
Tae-woo Lee
CTO
Participates in a number of projects
Hee-jeong Shin
Business Development
Participates in a number of projects
Yong-hyun Kim
Business Development
Participates in a number of projects
Tae-eun Kim
Business Development
Participates in a number of projects
Byung-ha Kim
Software Engineer
Participates in a number of projects
Hyun-sub Choi
Software Engineer
Participates in a number of projects
Back-seoung Choi
Software Engineer
Participates in a number of projects
Jung-min Yeom
Software Engineer
Participates in a number of projects
Do-Young Jeong
Software Engineer
Participates in a number of projects
Ji-yoo Choi
Marketing
Participates in a number of projects
Jung-won Lim
Marketing
Participates in a number of projects
Jin Woong Cho
Operation Managing
Participates in a number of projects
In-nyoung Choi
UX/UI Design
Participates in a number of projects
Myeong-jin Lee
UX/UI Design
Participates in a number of projects

Advisors (17)

Bernd Lapp
Participates in a number of projects
Yoon Sup Choi
Participates in a number of projects
Jihoon Jeong
Participates in a number of projects
Soo-yong Shin
No participating data
Gyu-ha Ryu
No participating data
Jae-won Shin
No participating data
Jong-hyuk Kim
No participating data
Tae-ho Kim
No participating data
Sungho Choi
Participates in a number of projects
Seung Jae Baek
No participating data
Soowoong Kim
No participating data
Jeong-nam Choi
No participating data
Pyung Shin
No participating data
Youngsung Min
No participating data
Young-hyuk Go
Participates in a number of projects
Jin-kyu Jang
Participates in a number of projects
Jeongyun Heo
Participates in a number of projects
ICO List
Other Interesting ICOs
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Stealthcrypto
The StealthCrypto® utility token will be the native cryptocurrency of the StealthCrypto® system. Funds collected through the token sale will be used to develop as well as activate and purchase StealthCrypto Cloud® products and products in the StealthCrypto® ecosystem. The values of StealthCrypto® tokens are fully dependent upon the developments of Stealth Grid™ and market demand.
Upcoming
Emrify Health Passport
Emrify is launching a decentralized Personal Health Record platform on top of the Ethereum public blockchain to deliver trusted health information to the right hands at the right time anywhere in the world. With years of building consumer engagement mobile apps, Emrify is laser focused on collecting and locking up data for each person for complete ownership and control to freely share their data. Our top priority is to create attractive cryptoeconomics models to incentivize health data sharing for all parties. With strategic US partnerships with hospitals and doctors, Emrify is building on top of established prototypes to accelerate the launch of production interfaces to firmly establish the Utility Token in healthcare.
Upcoming
Acta Finance
The first Cross-Chain Interoperable DeFi Ecosystem, built natively on Avalanche The ActaFi Ecosystem brings a complete DeFi suite that incentivises user-base growth and motivates the user activity, offering both DeFi products and features in a single ecosystem. Every interaction within the ActaFi Ecosystem is executed on-chain, by smart contracts.
Upcoming
Candao
"People can, DAO's do. Candao mission is to create a platform where individuals with the same business and social goals can come together to inspire, engage and build values together. Candao unlock people’s superpowers and let them tokenize the value they create, liquefy assets, connect existing ones, bring people together in order to build joint ventures, distribute profits between all involved people and unlock the value of everyone who plays different roles in everyday life."
Active
Tempo
Tempo is a French licensed, Paris-based, European-wide anchor for Stellar blockchain payments. The company offers online, offline and digital backed remittances to nearly 100 destination countries with over 300 physical agent locations. Tempo is creating the easiest, fastest and most secure bridge between cash and crypto.